In der Schweiz sind drei Studienteilnehmer bei einer experimentellen Zelltherapie gestorben – offenbar an einer bekannten Komplikation. Novartis hat nun mehrere Studien ausgesetzt.

Novartis a suspendat temporar, la sfârșitul lunii august, opt studii clinice pentru o terapie experimentală destinată tratării unor afecțiuni autoimune și

The halt was implemented on August 24 after Novartis was notified of three cases of a severe, life-threatening immune reaction. Complications from the reaction, in which the…